Based on our recent findings that MAPK1 mutation can alter ErbB family signaling in HNSCC (Van Allen et al, 2015), we thus examined the effects of various major hotspot MAPK pathway mutations on p-ErbB3(Y1289) expression. The gene discussed is ERBB3; the disease is head and neck squamous cell carcinoma.